Intrinsic Value

Avalo Therapeutics, Inc. (AVTX)

$21.75

+17.00 (+357.89%)

Enterprise Value -5,125.11
Net Debt 6.24
Equity Value -5,131.36
Shares Outstanding 9.41
Equity Value Per Share -545.40



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt